[Ketotifen in allergic diseases].

This study included the review of 1000 clinical histories of allergic diseases, in a retrospective way, that was seeing in the Service of Allergy of the Instituto Nacional de Pediatría in Mexico city. All the patients were previously diagnosed with several allergic pathologiest like: bronchial asthma, rhinitis, asthma and rhinitis, atopic dermatitis, etc. All the patients received as main therapeutic treatment ketotifen at least during 3 months to 12 months. Global improvement in all patients with the use of ketotifen, reach 84%, including all the pathologiest studied. The tolerance of the drug specially in children was very good.